We would love to hear your thoughts about our site and services, please take our survey here.
London South East prides itself on its community spirit, and in order to keep the chat section problem free, we ask all members to follow these simple rules. In these rules, we refer to ourselves as "we", "us", "our". The user of the website is referred to as "you" and "your".
By posting on our share chat boards you are agreeing to the following:
The IP address of all posts is recorded to aid in enforcing these conditions. As a user you agree to any information you have entered being stored in a database. You agree that we have the right to remove, edit, move or close any topic or board at any time should we see fit. You agree that we have the right to remove any post without notice. You agree that we have the right to suspend your account without notice.
Please note some users may not behave properly and may post content that is misleading, untrue or offensive.
It is not possible for us to fully monitor all content all of the time but where we have actually received notice of any content that is potentially misleading, untrue, offensive, unlawful, infringes third party rights or is potentially in breach of these terms and conditions, then we will review such content, decide whether to remove it from this website and act accordingly.
Premium Members are members that have a premium subscription with London South East. You can subscribe here.
London South East does not endorse such members, and posts should not be construed as advice and represent the opinions of the authors, not those of London South East Ltd, or its affiliates.
Indeed postings can get reposted once in a while, a company's career website is the best prime source for new vacancies most of the time. They have a number of vacancies going (and have since the summer).
It says this was posted 11 days ago.
https://uk.indeed.com/viewjob?jk=96310aaa6d161d9f
Group accounts should be published this month. As a PLC, I think they were RNS’d early Oct last year and available on the Companies House website, early Nov.
Also hold a significant amount here.
Great info and update. Thanks a lot, am also hoping for a happy ending here.
Good info. Thanks. Keep updating please. Im Sitting on a lot of shares in the hope things work out!
Previous accounts too have been re-submitted with Richard Pye’s signature as CFO, removing Drayson’s
Drayson’s signature. So Richard Pye has signed off old accounts.
Looks like they are making a clean start with corporate governance too.
This was this time last year. A lot has happened since with the Co though and whether collaboration with Bayer in Lifehub is still ongoing.
https://www.bayer.co.uk/en/lifehubuk-birthday
They seem to have made progress on separating the Co into parts. Looks like they have replaced PwC with Grant Thornton. All the big pharma cos, Bayer GSK etc have recently pledged more investment into AI. It’s whether a sale could still be considered if anyone is still interested or if the loan note holders want an ‘out’ with a realist in the US, sometime in the future. Also how long Alex Snow is willing to further develop the Co.
Sounds positive?
The division Sensyne Health Holdings made a profit of £22.7 m with net assets of £82m year ended Apr21. Grant Thornton audit signed off in Aug. All available at Companies House website.
As of 1st Aug 22 £6.5 m cash balance and £8 m still available to be drawn loan ( loan notes) at discretion of holders.
Divestments “ Complex clinical and regulatory pathway these products must operate in “ are having an impact on timing and completion
Agreement with OUHF Trust to our license SEND
Operations in magnifeye closed jul 22 although Technology available for acquisition.
A very comprehensive auditors report signed off by Grant Thornton just 4 weeks ago. Phesi collaboration seen as a 7 year benefit. ‘Going concern’ still very much in the hands of loan note holders. No divestment completed as of 26 Aug. It’s worth a read through and looks quite a ‘due diligence’ auditors and directors report warts and all.
That is For Sensyne Health Group Ltd, made up until April 2021.
Sorry not sure that link works but available on Companies House website.
£ or $, depends what report you read but the collaboration is valid for 5 years.
It was a £10 million equity investment in Phesi. ( not $ )
https://www.phesi.com/news/sensyne-grows-medical-research-dataset-to-60-million-patients/
One wonders what , if anything, has been happening with this collaboration and what Sen’s investment in Phesi is worth.
https://www.sensynehealth.com/newsroom/sensyne-health-and-phesi-enter-joint-commercial-development-collaboration-with-a-leading-pharmaceutical-company
Just as a reminder … 10 million dollars invested by Sens into Phesi
https://www.phesi.com/news/phesi-and-sensyne-health-agree-collaboration-to-advance-development-of-synthetic-arms-in-clinical-trials/
Wonder why Bayer parted with Exscientia.
Not a whiff anywhere yet of any divestments by Sensyne and I believe it was around the end of 2019 that Bayer signed a 2 year deal with Sensyne.
Agree re-listing unlikely anytime soon but wouldn’t rule out a sale.
I don't see a re-listing happening in this climate. I think the worst may yet be to come for the US market. Once we're over the hill and there is optimistic sentiment, then would be a good time to re-list.